What's New in Cardiac MRI? — July 09, 2026
AI-summarised digest of 62 PubMed articles on Cardiac MRI published in the last 7 days.
Jump to category
What’s New in Cardiac MRI?
July 09, 2026 · 62 articles · 15 research themes · covering July 02, 2026 – July 09, 2026
Overview
Across this week’s papers, a dominant thread is the push toward earlier, more precise cardiovascular diagnosis and risk stratification—often using cardiac MRI (CMR) and advanced imaging-derived biomarkers. Multiple studies highlight “silent” or early disease signals (e.g., unrecognized myocardial infarction in obesity, subclinical myocardial involvement in inherited or systemic conditions, and early HF risk in Stage B/HFpEF phenotypes), while others refine how CMR can distinguish reversible inflammation from fixed pathology, characterize diffuse fibrosis (e.g., ECV), and improve procedural planning (e.g., RVOT geometry for valve implantation, LV recovery prediction after valve surgery). Method-focused work (phantoms, free-breathing tissue mapping, and optimized contrast protocols) supports the practical goal of making these techniques more reliable and scalable.
A second major theme is mechanism-based personalization for arrhythmias and ischemic syndromes. Reviews and translational studies converge on targeted strategies—such as improving arrhythmic risk prediction beyond ejection fraction using deep learning on LGE, aligning CMR fibrosis with electroanatomical mapping for AF ablation, and using intracardiac electrogram ML to infer nonendocardial scar. In ischemic heart disease and MINOCA, mechanistic thinking is emphasized (e.g., coronary microembolization pathways and endotype-informed trial design), alongside evidence that some traditional paradigms (like broad viability-for-recovery decision-making) may have limited value in contemporary practice.
Finally, the digest also reflects broader health-system and clinical-care priorities: consensus-building frameworks for surgical management, standardized data elements for trauma research, and cost-effectiveness considerations for imaging. Outside cardiology, there are notable advances in infection prevention and treatment (nanoparticle ocular delivery for keratitis; evidence gaps for arterial catheter bloodstream infection prevention), plus public-health epidemiology linking exposures (asbestos, OSA) to downstream disease burden.
Cardiac MRI & Tissue Characterization Methods
Multimodality imaging of extensive caseous-calcific myocardial involvement mimicking a cardiac mass.
This report studied extensive caseous-calcific myocardial involvement that mimicked a cardiac mass in a 73-year-old asymptomatic obese woman undergoing pre-operative evaluation. Echocardiography suggested asymmetric septal hypertrophy with a large non-mobile hyperechogenic interventricular septal mass, and cardiac MRI characterized markedly reduced native T1/T2 values, hypoperfusion on first-pass perfusion, and peripheral late gadolinium enhancement around a non-enhancing calcified core. The clinical significance is that multiparametric CMR tissue characterization can distinguish calcific/caseous lesions from true cardiac tumors or other infiltrative masses.
Frittella S, Lo Monaco M, Mollace R et al. · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗
[Cardiovascular magnetic resonance imaging: routine use in cardiology and unique strengths].
This narrative article reviewed cardiovascular magnetic resonance (CMR) and focused on its routine clinical use and distinctive strengths across cardiology indications. It emphasized that CMR uniquely combines accurate functional assessment with non-invasive tissue characterization in one examination, including stress perfusion CMR for ischemia and late gadolinium enhancement (LGE) for viability, and CMR using Lake Louise criteria for inflammatory myocardial disease differentiation. Scientifically, it supports broader adoption of CMR as a comprehensive diagnostic platform rather than a single-purpose imaging test.
Schulz A, Reiter T · Innere Medizin (Heidelberg, Germany) · (2026) · View on PubMed ↗
Clinical Feasibility of Free-Breathing Volumetric Comprehensive Tissue Characterization via the Multi-parametric SAVA Technique.
This study assessed the clinical feasibility of free-breathing volumetric comprehensive tissue characterization using the multi-parametric SAVA (mSAVA) technique in patients, including pre-/post-contrast T1, T2, ECV, and synthesized bright-blood and dark-blood LGE. The key finding was that 3D free-breathing mSAVA produced measurable tissue parameters and LGE outputs that were compared against conventional T1 mapping, T2 mapping, and PSIR-based LGE approaches to evaluate agreement and performance. Clinically, it supports whether one-stop, volumetric CMR tissue mapping can be adopted in routine practice despite motion and workflow constraints.
Jiang Y, Si D, Cai Q et al. · Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · (2026) · View on PubMed ↗ · Free PDF ↗
Ferumoxytol dose optimization for three-dimensional whole-heart magnetic resonance imaging in patients with congenital heart disease.
This prospective study evaluated ferumoxytol dose escalation regimens (1 mg/kg→2 mg/kg or 2 mg/kg→3 mg/kg) for 3D whole-heart cardiovascular magnetic resonance (CMR) at 1.5 T in 45 pediatric and young patients with congenital heart disease. It assessed how sequential dosing affected image quality and blood-pool nulling inversion time (TI), a physiologic surrogate of post-contrast T1 shortening. Optimizing ferumoxytol dosing could improve pediatric CMR workflow and image reliability when using this off-label contrast agent.
Erdem S, Hussain T, El Jerbi A et al. · Pediatric radiology · (2026) · View on PubMed ↗ · Free PDF ↗
A Physiologic Left Ventricle Flow Phantom for 4D Flow MRI Applications and CFD Verification.
The authors developed a subject-specific, MRI-compatible left ventricle (LV) flow phantom with a closed-loop circulation system to reproduce cardiac motion for 4D flow MRI and computational fluid dynamics (CFD) verification. They reported that the phantom uses a PVA-based hydrogel to provide MRI contrast and stable, reusable mechanics while reproducing healthy end-diastolic and end-systolic LV geometries for high-fidelity model validation. This enables more reliable in vitro testing of 4D flow MRI and CFD pipelines without in vivo scan-time and motion-artifact limitations.
Wiegand M, Obermeier L, Dillinger H et al. · Annals of biomedical engineering · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiac MRI for Ischemia, Infarction & Microvascular Injury
Unmasking Coronary Microvascular Dysfunction in Hypertrophic Cardiomyopathy: Multimodality Imaging With Stress Cardiac MRI and Coronary CT Angiography.
This case report investigated coronary microvascular dysfunction (CMD) in a 21-year-old female with hypertrophic cardiomyopathy (HCM) using multimodality imaging with stress cardiac MRI and coronary CT angiography. Stress CMR and CT angiography were used to identify CMD and support the HCM diagnosis, while transthoracic echocardiography showed mild LV hypertrophy, reduced global longitudinal strain, and mildly increased LVOT gradients. The scientific significance is that combining stress CMR with coronary CT can unmask CMD in HCM, informing risk stratification and potential targeting of microvascular ischemia.
Ufuk F · Case reports in radiology · (2026) · View on PubMed ↗
Viability testing for guiding revascularization in ischemic cardiomyopathy.
This review studied the clinical role of myocardial viability testing to guide revascularization decisions in ischemic cardiomyopathy, focusing on evidence from contemporary revascularization strategies and guideline-directed medical therapy. It found that randomized trial data (including STICH and follow-up) indicate coronary artery bypass grafting (CABG) improves long-term survival largely independent of viability status, challenging the traditional viability-for-recovery paradigm. The implication is that viability testing may have a more limited or selective role in modern practice when deciding on revascularization.
Li KY, Dhingra NK, Patel R et al. · Current opinion in cardiology · (2026) · View on PubMed ↗
Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction Without Shock: The ST-Segment Elevation Myocardial Infarction Door to Unload Randomized Controlled Trial.
The STEMI-Door to Unload (DTU) randomized controlled trial studied whether mechanical left ventricular (LV) unloading using a transvalvular microaxial flow pump (TV-mAFP) combined with delayed reperfusion reduces infarct size versus reperfusion alone in patients with anterior ST-segment elevation myocardial infarction (STEMI) without cardiogenic shock. The key finding was that the LV unloading strategy was tested as a means to reduce infarct size by lowering LV wall tension/load during the ischemia-reperfusion window. This trial is clinically significant because it directly evaluates a preclinical LV-load–infarct-size mechanism in a high-risk anterior STEMI population where large infarcts drive subsequent heart failure and mortality.
Kapur NK, Mangner N, Aghili N et al. · Journal of the American College of Cardiology · (2026) · 5 citations · View on PubMed ↗
Association between CMR-derived pulmonary artery pulse wave velocity and pulmonary risk factors: the multi-ethnic study of atherosclerosis COPD study.
This prospective cohort study assessed the association between pulmonary artery pulse wave velocity (PA PWV), measured by cardiac magnetic resonance (CMR), and pulmonary risk factors—specifically smoking history—in participants from the Multi-Ethnic Study of Atherosclerosis (MESA) COPD cohort. The key finding was that PA stiffness quantified by CMR-derived PWV can be evaluated in relation to smoking exposure using 2-D phase-contrast flow and semi-automated PWV software. This is significant because it extends arterial stiffness biomarkers from systemic to pulmonary circulation, potentially improving understanding of pulmonary vascular risk in COPD-related populations.
Huurman R, Xie E, Ohyama Y et al. · Magnetic resonance imaging · (2026) · View on PubMed ↗
Prevalence and prognostic impact of unrecognized myocardial infarction detected by cardiac magnetic resonance in Thai patients with obesity.
This cohort study evaluated the prevalence and prognostic impact of unrecognized myocardial infarction (UMI) detected by cardiac magnetic resonance (CMR) in 1,053 Thai patients with obesity (BMI ≥25 kg/m2) without prior MI or coronary revascularization. The key finding was that CMR-detected UMI is common in this obese population and carries prognostic implications for future outcomes. This is significant because it supports CMR as a tool for identifying silent myocardial injury in Asian patients with obesity, where risk may be under-recognized clinically.
Chayanopparat P, Siriphiphatcharoen P, Laohabut I et al. · PloS one · (2026) · View on PubMed ↗ · Free PDF ↗
Molecular mechanisms of coronary microembolization-induced MINOCA.
The article reviewed and investigated the molecular mechanisms underlying coronary microembolization (CME) as a key cause of myocardial infarction with non-obstructive coronary arteries (MINOCA). It highlights that MINOCA diagnosis is often delayed because cardiac MRI is typically performed days after the index event, and it notes that the lack of mechanistic understanding limits rapid diagnostic tools and targeted therapy. Scientifically, clarifying CME molecular pathways could enable earlier MINOCA diagnosis and development of specific interventions for microvascular embolic injury.
Iske J, Thau H, Mesfin JM et al. · Basic research in cardiology · (2026) · View on PubMed ↗ · Free PDF ↗
Characteristics and outcomes of patients undergoing coronary computed tomography angiography for suspected acute coronary syndrome in the emergency department.
This retrospective cohort study assessed clinical characteristics and outcomes of 198 emergency department patients with suspected acute coronary syndrome (ACS) who underwent coronary computed tomography angiography (CCTA) between 2020 and 2022. The primary endpoint was a composite major adverse cardiovascular event (MACE) outcome (all-cause death, acute myocardial infarction, or myocardial revascularization), and the study characterized event rates and patient features associated with outcomes. The results support evidence-based use of CCTA in ED triage for suspected ACS by clarifying prognostic implications of CCTA evaluation.
Ciliberti G, Compagnucci P, Finori L et al. · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗
Enhanced risk stratification in hypertrophic cardiomyopathy through the integration of extracellular volume fraction on cardiovascular magnetic resonance.
This study analyzed 990 consecutive hypertrophic cardiomyopathy (HCM) patients undergoing cardiovascular magnetic resonance (CMR) from 2012–2024 to test whether global extracellular volume fraction (ECV), a marker of diffuse interstitial fibrosis, adds prognostic value beyond late gadolinium enhancement (LGE). During a median 3.2-year follow-up, CMR-derived ECV and LGE were associated with HCM-related events (sudden cardiac death events, heart failure events, and HCM-related death), with ECV providing incremental risk stratification. Clinically, integrating ECV with LGE could refine prediction of adverse outcomes in HCM and improve patient selection for closer monitoring or therapy.
Lee HJ, Gwak SY, Lee S et al. · European heart journal. Cardiovascular Imaging · (2026) · View on PubMed ↗
Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.
This registry-based basket trial is designed to stratify treatment in patients with myocardial infarction with no obstructive coronary arteries (MINOCA) or nonischemic myocardial injury by focusing on coronary microvascular dysfunction endotypes. It aims to (1) determine the prevalence and prognostic implications of coronary microvascular dysfunction in suspected MINOCA and (2) test endotype-informed stratified medicine using eplerenone versus standard approaches in patients with microvascular dysfunction. The scientific significance lies in moving beyond undifferentiated MINOCA care toward mechanism-based therapy selection using a targeted mineralocorticoid receptor antagonist.
Sykes R, Tan D, McKinley G et al. · American heart journal · (2026) · View on PubMed ↗ · Free PDF ↗
Heart Failure (including HFpEF/HFrEF) Risk, Prevention & Cost/Access
Cost-effectiveness of imaging modalities in coronary heart disease: A comprehensive review.
This 2026 comprehensive review studied the cost-effectiveness of imaging modalities for coronary heart disease (CHD), focusing on myocardial perfusion imaging (MPI) using SPECT and PET. The key finding was that economic evaluations increasingly emphasize careful selection of imaging modality as costs rise and imaging technology advances, with MPI remaining a cornerstone diagnostic strategy. This is significant for health systems because it frames how to balance clinical value and resource use when choosing SPECT versus PET MPI in CHD care.
Milan E, Giubbini R, Vitola J et al. · Seminars in nuclear medicine · (2026) · View on PubMed ↗
The HFpEF-ABA score predicts adverse cardiac remodelling and incident heart failure: a UK biobank study.
The study evaluated whether the HFpEF-ABA score (age, body mass index, atrial fibrillation) predicts adverse cardiac remodeling and incident heart failure in a large UK Biobank community cohort without baseline heart failure or structural heart disease. Using cardiac magnetic resonance phenotyping and long-term outcome follow-up, it found that higher HFpEF-ABA score categories are associated with increased risk of adverse remodeling and future HF events. This supports the HFpEF-ABA score as a potential preventive screening tool to identify individuals at preclinical risk for HFpEF-related deterioration.
Shi Q, Gao Y, Chen D et al. · ESC heart failure · (2026) · View on PubMed ↗ · Free PDF ↗
Diagnostic Tests for Stage B Heart Failure.
This 2026 review synthesized guideline- and study-based evidence on diagnostic tests for Stage B heart failure (SBHF), focusing on detecting subclinical myocardial remodeling and early injury before symptom onset. It emphasizes transthoracic echocardiography—particularly speckle tracking echocardiography—as a cornerstone diagnostic approach, alongside circulating biomarkers such as natriuretic peptides and high-sensitivity cardiac troponins. The review supports a multimodal diagnostic strategy to identify early HF risk in patients who have not yet developed overt symptoms.
Dang HNN, Luong TV, Huynh Q et al. · Current cardiology reports · (2026) · View on PubMed ↗ · Free PDF ↗
Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.
The POLY-HF randomized trial studied whether a once-daily heart failure polypill strategy improves cardiac function compared with rapid uptitration of individual guideline-directed medical therapy in adults with heart failure with reduced ejection fraction (LVEF ≤40%) at two centers. The trial enrolled a predominantly underserved population and tested a fixed-dose combination containing metoprolol succinate (25/50/100/150 mg), spironolactone 12.5 mg, and empagliflozin 10 mg versus enhanced usual care. If effective, this approach is clinically significant because it could improve access and adherence to evidence-based therapies in real-world, resource-limited settings.
Pandey A, Keshvani N, Rizvi SK et al. · Nature medicine · (2026) · View on PubMed ↗
Arrhythmias & Electrophysiology (AF/VT/PVC/SCD) & Ablation
Atrial Fibrosis Imaging: Correlation of Late Gadolinium Enhancement Magnetic Resonance Imaging With High-Definition Voltage Electroanatomical Mapping Across Different Thresholds.
This prospective study correlated atrial fibrosis quantified by late gadolinium enhancement (LGE) CMR with high-definition voltage electroanatomical mapping across different thresholds in 60 ablation-naïve patients with atrial fibrillation scheduled for first-time catheter ablation. Using a 1.5T system with a high-resolution 1.3 mm isotropic free-breathing 3D LGE sequence and whole-heart coverage, the authors assessed how CMR-derived fibrosis extent aligns with electroanatomical voltage-defined scar depending on the chosen threshold. The clinical significance is that establishing CMR–electroanatomical concordance could improve noninvasive atrial fibrosis assessment for AF ablation planning and recurrence risk prediction.
Efremidis T, Nyktari E, Kariki O et al. · Journal of cardiovascular electrophysiology · (2026) · View on PubMed ↗
Identifying the Presence and Characteristics of Mid-Myocardial and Epicardial Fibrosis From Intracardiac Electrograms in Patients Undergoing Ventricular Arrhythmia Ablation Using a Transformer-Based Self-Supervised Classifier.
This study investigated whether intracardiac electrograms can be used to infer nonendocardial myocardial scar (mid-myocardial and epicardial fibrosis) during ventricular arrhythmia ablation using a transformer-based self-supervised machine-learning classifier in patients undergoing catheter ablation. It found that electrogram-derived information can be leveraged by the model to identify fibrosis characteristics beyond the endocardial surface, addressing limitations of delayed enhancement CMR. This could enable more accurate intra-procedural substrate targeting without relying on preprocedural CMR in patients with workflow or device-related constraints.
Liu X, Qayyum A, Bandyopadhyay S et al. · Circulation. Arrhythmia and electrophysiology · (2026) · View on PubMed ↗
Multiomics Insights Into the Role of Spondin-1 in the Pathogenesis and Prognosis of Atrial Fibrillation.
This multiomics study investigated spondin-1 (SPON1) as a molecular driver of atrial fibrillation (AF) by integrating Mendelian randomization and colocalization using plasma protein quantitative trait loci (pQTL) and atrial expression quantitative trait loci (eQTL) with AF genome-wide association studies. It prioritized SPON1 and further characterized it using single-nucleus RNA sequencing, spatial transcriptomics, and experimental validation, linking SPON1 to AF pathogenesis and clinical relevance (abstract truncated). If validated, SPON1 could become a novel biomarker or therapeutic target for AF-related structural remodeling.
Long X, Zhang Y, Gao X et al. · Journal of the American Heart Association · (2026) · View on PubMed ↗ · Free PDF ↗
Targeting Arrhythmogenic Late Sodium Current by FHF1A-Derivative FixR in Heart Failure Cardiomyocytes.
The researchers investigated whether an engineered peptide inhibitor, FixR (an FHF1A-derivative; “FHF inhibiting x region”), can target the arrhythmogenic late sodium current (INa,L) in human heart failure cardiomyocytes and relevant HFrEF/HFpEF models. They found that INa,L is modulated by FGF homologous factors (FHF1–4) and that FixR alters INa,L–linked proarrhythmic mechanisms, with RT-qPCR used to profile cardiac sodium channel and FHF splice isoforms in human and animal systems. This supports a gene-pathway–targeted therapeutic strategy for reducing arrhythmia risk in heart failure by inhibiting FHF-dependent regulation of INa,L.
Hegyi B, Angsutararux P, Chakouri N et al. · Circulation research · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗
Improving arrhythmic risk prediction using cardiac magnetic resonance within deep learning in ischemic heart disease.
This study assessed whether deep learning applied to late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) improves arrhythmic risk prediction in ischemic heart disease (IHD) beyond conventional clinical markers like left ventricular ejection fraction. Using two independent IHD cohorts (including REVIVED-BCIS2-derived data), it found that LGE-CMR–based deep learning features provide incremental prognostic value for sudden arrhythmic death risk. Clinically, this could refine risk stratification and guide management decisions in IHD patients by leveraging scar burden and heterogeneity captured by CMR.
Sen A, Jones RE, Morgan H et al. · NPJ cardiovascular health · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiac MRI-based strain analysis for the assessment of left atrial dysfunction in patients with atrial fibrillation.
This retrospective study evaluated cardiac magnetic resonance feature tracking (CMR-FT) left atrial (LA) strain parameters in 113 patients with atrial fibrillation (AF) and 52 age- and sex-matched healthy controls. AF patients showed impaired LA functional measures (including LA ejection fraction and strain components εs, εe, and εa), and the study aimed to identify CMR-FT-derived strain indicators that detect early LA dysfunction beyond conventional static LA size/function metrics. These findings suggest CMR-FT LA strain could improve early risk assessment of AF-related atrial myocardial impairment and guide earlier intervention.
Zhou H, Zhu D, Hao S et al. · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗ · Free PDF ↗
Revisiting the Link Between Substrate and Ventricular Tachycardia Rate: The Critical Role of Conduction Isthmus Structure and Function.
This prospective cohort study evaluated whether local conduction-isthmus substrate features better predict ventricular tachycardia (VT) rate than global substrate metrics in 62 patients undergoing ablation for scar-related VT. Using high-density electroanatomical mapping and late gadolinium-enhanced cardiac MRI, the investigators compared global measures (e.g., total activation time and deceleration zone metrics) with isthmus-specific conduction-isthmus structure and function to determine which substrate properties track VT rate. The findings are significant for improving VT risk stratification and ablation targeting by identifying the substrate elements most responsible for VT cycle-rate behavior.
Guichard JB, Castrillo-Golvano L, Molero-Pereira S et al. · Heart rhythm · (2026) · View on PubMed ↗ · Free PDF ↗
Treatment of Premature Ventricular Contractions: A Review of Medical Therapy, Catheter Ablation, and Emerging Treatments.
This review studied medical therapy, catheter ablation, and emerging treatments for premature ventricular contractions (PVCs) across patients with and without structural heart disease. It found that treatment selection should be guided by symptom burden, PVC frequency, ventricular function, and underlying myocardial disease, with catheter ablation and newer approaches considered particularly when PVCs drive cardiomyopathy or significant arrhythmia risk. Scientifically and clinically, it consolidates diagnostic and therapeutic strategies to reduce PVC-related morbidity and prevent progression to PVC-induced cardiomyopathy or malignant ventricular arrhythmias.
Elattar S, Hodhod A, Basha NR et al. · Cardiology in review · (2026) · View on PubMed ↗
Cardiomyopathies & Genetic/Inherited Heart Disease
An unexpected sequel to happiness: happy heart syndrome.
This case report studied takotsubo cardiomyopathy’s rare “happy heart syndrome” trigger in a 65-year-old woman with hypertension, diabetes mellitus, and dyslipidemia who developed anginal chest pain after attending a wedding. The patient showed transient anterolateral ST-segment elevation with rapid ECG normalization, elevated troponin (717 ng/L), and subsequent QT prolongation with T-wave inversion, consistent with stress-induced cardiomyopathy rather than obstructive coronary disease. Clinically, it highlights that positive emotional events can precipitate takotsubo/HHS and that serial ECG and biomarkers are crucial for timely recognition and differentiation from acute coronary syndromes.
Rhabneh L, Wafi J, Ababneh R et al. · Oxford medical case reports · (2026) · View on PubMed ↗
Sex-disaggregated data in hypertrophic cardiomyopathy: a targeted literature review, meta-analysis and primary cohort study.
This study examined sex-disaggregated clinical and imaging data in hypertrophic cardiomyopathy (HCM) using a targeted literature review, meta-analysis, and a primary cohort analysis. The key finding was that sex-based differences in presentation, progression, and outcomes are supported by aggregated echocardiographic and cardiac MRI measures including sex-disaggregated NT-proBNP values (as captured in the authors’ meta-analysis and cohort). The significance is that incorporating sex-specific physiology and biomarkers may improve prognostication and guide more tailored management strategies in HCM.
Lim VG, Kokara M, Jarrett A et al. · Open heart · (2026) · View on PubMed ↗
Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry.
This registry-based study investigated the natural history and predictors of major adverse cardiovascular events (MACE) in phenotypically mild hypertrophic cardiomyopathy (HCM) using the SHaRe Registry (Sarcomeric Human Cardiomyopathy Registry). The key finding was that among patients with phenotypically mild HCM—defined by shorter disease duration (<10 years since diagnosis or age ≤30 years), NYHA class I, and no prior MACE—specific baseline characteristics predicted incident MACE and helped characterize disease progression over time. The clinical significance is that identifying predictors in early/mild HCM may enable selection of patients who could benefit from future disease-modifying strategies.
Topriceanu CC, Balakrishnan ID, Vissing CR et al. · Journal of the American College of Cardiology · (2026) · 1 citations · View on PubMed ↗
Obstructive sleep apnea and rising cerebrovascular disease mortality in the United States, 1999-2020: A retrospective analysis.
This retrospective analysis studied whether obstructive sleep apnea (OSA) is associated with rising cerebrovascular disease mortality in the United States from 1999 to 2020, stratifying adults by gender, race, urbanization, and geographic region. It reported age-adjusted mortality comparisons for cerebrovascular disease among adults with OSA across the study period (details truncated in the abstract). If confirmed, these findings would strengthen the public-health rationale for OSA detection and treatment to reduce cerebrovascular mortality.
Zafar F, Jha M, Min S et al. · Sleep & breathing = Schlaf & Atmung · (2026) · View on PubMed ↗
Left ventricular excessive trabeculation: pathophysiology, diagnostic challenges, and prognostic significance.
This review studied left ventricular excessive trabeculation (LVET) and its relationship to left ventricular non-compaction (LVNC), focusing on pathophysiology, diagnostic challenges, and prognostic significance across physiological and pathological settings. It found that LVET may represent a heterogeneous phenotypic trait driven by genetic factors, embryonic developmental processes, and acquired hemodynamic adaptations rather than a single embryologic arrest mechanism. Scientifically and diagnostically, this reframes how clinicians interpret LVET/LVNC imaging patterns and how prognosis may vary by underlying etiology.
Beltrami M, Maestrini V, Baritussio A et al. · Heart failure reviews · (2026) · View on PubMed ↗
Clinical Course and Predictors of Heart Failure in Asymptomatic Obstructive Hypertrophic Cardiomyopathy.
This multicenter retrospective study examined the clinical course and predictors of progression to symptomatic heart failure in 341 asymptomatic adults with obstructive hypertrophic cardiomyopathy (NYHA class I, LVEF >50%, LV outflow tract gradient ≥30 mmHg) across four centers from 2003–2023. It identified baseline and clinical factors associated with subsequent development of symptomatic heart failure (truncated abstract limits which specific predictors are listed). These results can refine risk stratification and surveillance strategies for asymptomatic obstructive hypertrophic cardiomyopathy patients.
Schulz A, Maron MS, Peng LW et al. · Journal of the American Heart Association · (2026) · View on PubMed ↗ · Free PDF ↗
VCAM-1 as a biomarker of early cardiac phenotypic changes in Fabry disease.
This exploratory single-center cross-sectional study investigated whether vascular cell adhesion molecule-1 (VCAM-1) is associated with early cardiac phenotypic changes in Fabry disease (FD) adults, comparing 14 genetically confirmed FD adults from a family carrying the GLA p.Arg363His variant with 30 matched healthy controls. The key finding was that VCAM-1, as an endothelial activation biomarker, is linked to early cardiac phenotypic changes in this FD cohort. This is clinically significant because it suggests VCAM-1 could serve as an early biomarker of cardiac involvement in FD, potentially enabling earlier risk stratification and monitoring.
Lino DODC, Meneses GC, de Almeida IM et al. · BMC cardiovascular disorders · (2026) · View on PubMed ↗ · Free PDF ↗
Sudden Cardiac Arrest and Takotsubo-Like Cardiomyopathy as the Initial Presentation of Primary Carnitine Deficiency.
This JACC Case Reports report describes an 18-year-old woman who presented with ventricular fibrillation cardiac arrest and was found on cardiac magnetic resonance to have a Takotsubo-like cardiomyopathy phenotype. Genetic testing identified a homozygous pathogenic variant in SLC22A5 (c.43G>T; p.Gly15Trp), confirming autosomal recessive primary carnitine deficiency (PCD) as the cause of the initial presentation. The case highlights that PCD can present with sudden cardiac arrest and stress-cardiomyopathy-like imaging, emphasizing the need for rapid genetic/metabolic evaluation because PCD is treatable.
Talasani N, Przybylski R, Delaney MA et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Inflammatory Myocardial Disease & Myocarditis/Sarcoidosis
Multimodality imaging of myocardial injury and coronary microvascular dysfunction in congenital thrombotic thrombocytopenic purpura.
This case report studied subclinical cardiac involvement in congenital thrombotic thrombocytopenic purpura (cTTP) due to ADAMTS13 deficiency, using multimodality imaging to evaluate myocardial injury and coronary microvascular dysfunction. The key finding was that an affected patient who temporarily discontinued enzyme replacement therapy showed myocardial fibrosis/scarring and impaired myocardial flow reserve, indicating microvascular dysfunction despite subclinical presentation. Scientifically, it supports using cardiac MRI together with PET perfusion imaging to detect early cardiac complications in cTTP and to monitor effects of therapy interruption.
Kumar A, Khokhlov L, O’Donnell R · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗
Arrhythmic Myocarditis and Prevention of Sudden Cardiac Death: Current Evidence, Risk Stratification, and Management.
This review studied arrhythmic presentations of acute myocarditis and how to stratify sudden cardiac death (SCD) risk using clinical features, ventricular arrhythmia burden, genetic variants, and cardiac magnetic resonance (CMR) findings such as late gadolinium enhancement in affected patients. It found that ventricular arrhythmias occur in about 10% of hospitalized acute myocarditis patients, often during the early inflammatory phase, and that SCD risk assessment should integrate multimodal data including CMR scar markers and genetic susceptibility. Clinically, this supports more tailored monitoring and management strategies for myocarditis patients at higher risk of malignant ventricular arrhythmias and SCD.
Imazio M, Collini V, Tomat M et al. · Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese · (2026) · View on PubMed ↗ · Free PDF ↗
From inflammation to inheritance: rethinking myocarditis as the first signal of desmosomal cardiomyopathy.
The study reviewed emerging evidence that acute myocarditis can be the first clinical signal of inherited desmosomal cardiomyopathy, focusing on desmosomal gene dysfunction (variants in desmosomal genes such as desmoglein/desmocollin family members, truncated in the abstract). It highlights an overlap between myocarditis phenotypes and genetic desmosomal cardiomyopathies supported by molecular genetics, cardiac magnetic resonance (CMR), and translational pathology. This reframes myocarditis evaluation toward earlier genetic and imaging assessment to identify patients at risk for desmosomal arrhythmogenic cardiomyopathy rather than treating it as purely inflammatory.
AbdelMassih AF, Sankari AC, Mallouka G et al. · The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · (2026) · View on PubMed ↗ · Free PDF ↗
A hidden threat in the apical shadow: a case report regarding Loeffler endocarditis mimicking NSTEMI.
This case report studied a 71-year-old man with long-standing idiopathic hyper-eosinophilia presenting with chest pain and progressive dyspnoea, ultimately diagnosed with Loeffler endocarditis (a cardiac manifestation of hyper-eosinophilic syndrome, HES). Cardiac MRI demonstrated apical endocardial fibrosis with intracavitary thrombus, and the patient was treated successfully with corticosteroids plus vitamin K antagonist anticoagulation. The report emphasizes that Loeffler endocarditis can mimic NSTEMI and that early CMR-driven diagnosis is critical to prevent restrictive cardiomyopathy and thromboembolic complications.
Caruzzo CA, Rigamonti E, Scopigni FR et al. · European heart journal. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Fully quantitative CMR rest perfusion reveals myocardial perfusion abnormality in Kawasaki disease: Association with left ventricular Remodeling.
This prospective single-center study examined children with Kawasaki disease (KD) using fully quantitative CMR rest perfusion to map myocardial perfusion abnormalities and relate them to left ventricular (LV) remodeling. It measured myocardial blood flow (MBF) corrected for heart rate–blood pressure product (MBFcor) and found associations between perfusion abnormalities and subsequent LV remodeling metrics. Clinically, quantitative rest perfusion CMR may help characterize myocardial injury distribution in KD and identify patients at risk for adverse LV remodeling.
Zhou Z, Ye P, Wang C et al. · International journal of cardiology · (2026) · View on PubMed ↗
Lyme Myopericarditis With Effusive-Constrictive Physiology: Serial CMR Identifies a Reversible Inflammatory Phenotype.
This case report describes a 45-year-old man with Lyme myopericarditis and effusive-constrictive physiology, where serial cardiac magnetic resonance (CMR) was used to distinguish inflammatory from fixed constrictive physiology. The patient’s CMR findings supported a reversible inflammatory phenotype rather than irreversible constriction, with management implications for treating inflammation. The report demonstrates how serial CMR can directly influence clinical decision-making in rare Lyme-associated pericardial syndromes.
Alhirtani N, Bigham G, Fabrizio C et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Prognosis of acute myocarditis beyond hospitalization: Results of a long-term prospective study.
This prospective single-center observational study followed 158 patients admitted with acute myocarditis (AM) between 2007 and 2022 to evaluate prognosis beyond hospitalization. Over long-term follow-up with annual clinical assessment, treadmill testing, Holter monitoring, and echocardiography, the study reported low but clinically important rates of severe complications (including cardiogenic shock or arrhythmic storm at 3.6%) and characterized longer-term outcomes using Cox regression. The results inform counseling and follow-up planning after AM by clarifying the risk trajectory after the acute episode.
de Freitas Vilela MM, Martins AM, Cazeiro D et al. · Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology · (2026) · View on PubMed ↗ · Free PDF ↗
Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?
This review assessed the contemporary role of endomyocardial biopsy (EMB) in diagnosing cardiac sarcoidosis (CS) within a multidisciplinary diagnostic framework. It highlights that EMB—despite being historically considered a diagnostic gold standard—has limited sensitivity with false negatives and can be risky, driving increased reliance on noninvasive imaging. The review’s synthesis is clinically significant because it frames when tissue diagnosis may still be necessary versus when modern imaging strategies may suffice in suspected CS.
Pericao A, Sharma R · Current opinion in pulmonary medicine · (2026) · View on PubMed ↗
Valvular Heart Disease & Structural Interventions (TAVR/TEER/Surgery)
Trileaflet mitral valve in hypertrophic obstructive cardiomyopathy: A rare anatomical variant requiring surgical intervention.
This case report describes a 68-year-old woman with hypertrophic obstructive cardiomyopathy (HOCM) who had symptomatic left ventricular outflow tract obstruction (resting gradient up to 87 mmHg) and severe mitral regurgitation. Multimodal imaging (cardiac magnetic resonance and echocardiography) identified a rare trileaflet mitral valve variant with anterior leaflet restriction and a clefted posterior leaflet, and symptoms persisted despite beta-blocker therapy, leading to surgical intervention. The case underscores that unusual mitral valve anatomy can drive obstruction and regurgitation in HOCM and may require surgery when medical therapy fails.
Kumar UA, Sitaranjan DR, Taghavi FJ · Perfusion · (2026) · View on PubMed ↗
An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.
This narrative review synthesized evidence and proposed a structured patient-selection framework for mitral transcatheter edge-to-edge repair (M-TEER) in patients with secondary mitral regurgitation (SMR), integrating randomized trial data (notably MITRA-FR and COAPT), proportionality concepts, and multimodality imaging. It attributes divergent trial outcomes largely to differences in echocardiographic selection and left-ventricular remodeling, emphasizing that SMR severity should be interpreted relative to ventricular size and regurgitant context. The proposed framework is significant for improving who benefits from M-TEER by aligning imaging-based selection with underlying ventricular remodeling biology.
Brusosa M, Flores-Umanzor E, Horlick E · Current opinion in cardiology · (2026) · View on PubMed ↗
Cardiac Imaging Predictors of Ventricular Recovery in Pediatric Patients Undergoing Aortic Valve Intervention for Regurgitation.
This retrospective study investigated preoperative cardiac imaging predictors of left ventricular (LV) recovery in pediatric and young adult patients (<30 years) undergoing aortic valve surgery for chronic aortic regurgitation (AR). Using echocardiogram and cardiac magnetic resonance (CMR) parameters, it aimed to identify which baseline imaging features are associated with postoperative LV reverse remodeling in a population where adult-derived surgical thresholds may not apply. The clinical significance is earlier and more accurate identification of children who are likely to recover LV function after intervention, potentially refining timing of aortic valve repair or replacement.
Flerlage EK, Huma LC, Gandhi R et al. · Pediatric cardiology · (2026) · View on PubMed ↗
Cardiac Biomarkers & Risk Prediction (non-imaging and imaging-derived)
Cardiac myosin-binding protein C in ST-elevation myocardial infarction.
This study evaluated cardiac myosin-binding protein C (cMyC) as a biomarker of myocardial injury in reperfused acute ST-elevation myocardial infarction (STEMI), comparing it against hs-cTnI and cardiovascular magnetic resonance (CMR) endpoints. The key findings tested were that cMyC correlates with acute and final MI size measured by LGE CMR and that cMyC is associated with the presence of acute microvascular obstruction (MVO) on CMR. The scientific significance is that if validated, cMyC could enable earlier MI diagnosis and improved detection of microvascular injury beyond conventional troponin timing.
Rajakulasingam R, Alaour B, McGrath S et al. · European heart journal. Acute cardiovascular care · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗
Diagnostic and Prognostic Utility of Mitral Annular Plane Systolic Excursion: A Systematic Review and Meta-Analysis.
This systematic review and meta-analysis studied the diagnostic and prognostic utility of mitral annular plane systolic excursion (MAPSE) measured by transthoracic echocardiography (and also possible by transesophageal echocardiography and cardiac computed tomography) across clinical studies. It found that MAPSE is a fast, simple, and potentially automatable measure of longitudinal systolic function with evidence supporting diagnostic and prognostic associations, despite limited guideline endorsement for routine use. The findings support MAPSE as a practical imaging biomarker that may improve risk assessment when incorporated into echocardiographic evaluation.
Falconer D, Fröjdh F, Wyeth N et al. · Journal of the American Heart Association · (2026) · View on PubMed ↗ · Free PDF ↗
Integrative Observational and Genetic Evidence From the UK Biobank Supports Carotid Intima-Media Thickness as a Window Into Cardiac Remodeling.
This UK Biobank integrative observational and genetic study analyzed 46,102 participants with carotid ultrasound and cardiac magnetic resonance imaging to test whether carotid intima-media thickness (cIMT) reflects cardiac remodeling and shares genetic architecture with cardiovascular disease. It found phenotypic and genetic associations linking cIMT to aortic and cardiac traits and to cardiovascular disease outcomes (specific effect estimates truncated). This supports cIMT as a window into early cardiac remodeling processes and suggests shared biological pathways between vascular thickening and cardiac structural changes.
Chong SH, Saccoh AF, van Vugt M et al. · Journal of the American Heart Association · (2026) · View on PubMed ↗ · Free PDF ↗
Characteristic flow of different right ventricular outflow tract morphology in repaired tetralogy of fallot patients studied by 4D-flow cardiac magnetic resonance images.
This retrospective study analyzed right ventricular outflow tract (RVOT) flow patterns in 120 patients with repaired tetralogy of Fallot (rTOF) using 4D-flow cardiac magnetic resonance (CMR), classifying RVOT morphology as tubular or pyramidal (with other morphologies excluded due to small numbers). The key finding was that distinct RVOT morphologies show characteristic 4D-flow hemodynamic patterns that may relate to pulmonary valve implantation suitability. This is significant for procedural planning because RVOT geometry can influence transcatheter pulmonic valve implantation (PPVI) feasibility and outcomes.
Srivichean A, Chungsomprasong P, Sanwong Y et al. · BMC medical imaging · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiovascular Pharmacology & Drug Toxicity
Fluoropyrimidine Cardiotoxicity: Role of Uridine Triacetate and Pharmacogenomic Insights from a Case of 5-FU-Induced Cardiogenic Shock.
This 2026 review studied fluoropyrimidine cardiotoxicity, emphasizing the role of uridine triacetate and providing pharmacogenomic insights from a case of 5-fluorouracil (5-FU)-induced cardiogenic shock. The key finding was that severe cardiotoxicity can occur across a spectrum beyond vasospasm, and that uridine triacetate and pharmacogenomic considerations may inform management and risk interpretation in fluoropyrimidine-treated patients. This is clinically significant because it supports more targeted prevention/therapy strategies for life-threatening fluoropyrimidine cardiac events.
Filomia S, Del Buono MG, Saponara G et al. · Journal of cardiovascular pharmacology · (2026) · View on PubMed ↗
Infectious Disease & Antimicrobial Delivery (ocular/CRBSI/keratitis)
Frontiers in Ocular Therapy: Linking Nanoparticles to Patho- Therapeutic Outcomes in Keratitis Treatment.
This 2026 review studied emerging nanotechnology-based ocular drug delivery approaches to improve patho-therapeutic outcomes in microbial keratitis, focusing on how nanoparticles can address poor ocular bioavailability, tear clearance, and antimicrobial resistance. The key finding was that nanoparticle strategies (e.g., improved delivery and targeting, including combination approaches) are positioned to overcome limitations of conventional keratitis therapies. This is scientifically significant because it synthesizes translational pathways for nanoparticle therapeutics aimed at reducing vision loss from bacterial, fungal, and viral keratitis.
Tiwari R, G D, Mohan VK et al. · Recent advances in anti-infective drug discovery · (2026) · View on PubMed ↗
Prevention of arterial catheter-related bloodstream infections: current evidence and future directions.
This 2026 review studied the evidence base for preventing arterial catheter-related bloodstream infections (AC-CRBSI) by examining strategies during arterial catheter insertion and maintenance. The key finding was that, unlike central venous catheter prevention, direct evidence for arterial catheter-specific best practices is limited and guidelines are inconsistent, though several insertion/maintenance measures appear valuable. This is clinically significant because it identifies gaps in AC-CRBSI prevention research and supports the need for arterial-catheter–focused trials to reduce bloodstream infection risk in critical care.
Donner V, Sadeghi CD, Catho G et al. · Critical care (London, England) · (2026) · View on PubMed ↗ · Free PDF ↗
Oncology & Cancer-Related Cardiac Complications
Rare Late Cardiac Involvement Following Resected Primary Limb Dedifferentiated Liposarcoma: A Case Report.
This case report studied rare late cardiac involvement after resected primary limb dedifferentiated liposarcoma (DDLPS) in a 68-year-old woman presenting with progressive dyspnea and found to have a mediastinal mass with pericardial involvement. Cardiac magnetic resonance (CMR) demonstrated imaging features consistent with malignant sarcoma, including heterogeneous enhancement and tissue characteristics supporting metastatic/secondary cardiac disease. The report is significant because it highlights the diagnostic value of CMR for uncommon, late cardiac metastasis in DDLPS and underscores the clinical challenge of recognizing sarcoma-related cardiac disease.
Alizadehasl A, Baghyari S, Salimi M · Clinical case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Surgical/Clinical Consensus & Care Pathways (non-cardiac and cross-cutting)
Learning curves in Versius-assisted colorectal surgery: a risk-adjusted CUSUM analysis from a single center.
This retrospective single-center study evaluated procedure- and operator-specific learning curves for Versius-assisted colorectal cancer surgery in consecutive adults undergoing right hemicolectomy, sigmoid resection, or anterior rectal resection between December 2022 and August 2025. Using risk-adjusted CUSUM (RA-CUSUM) of skin-to-skin operative time (adjusted for patient- and procedure-specific variables), the authors assessed how quickly teams reached proficiency for each procedure type. These findings can inform training and credentialing strategies for Versius robotic colorectal surgery by quantifying when performance stabilizes for specific operations.
Sachańbiński T, Miodoński M, Kropieniewicz J · International journal of colorectal disease · (2026) · View on PubMed ↗ · Free PDF ↗
A Global Consensus Conference on Surgical Management of Primary Uterovaginal Prolapse and Lower Urinary Tract Dysfunction: Combining Evidence with Expert Opinion.
This global consensus conference studied best-practice surgical management for primary uterovaginal pelvic organ prolapse (U-POP) and associated lower urinary tract dysfunction, convening geographically diverse expert committees to address controversial decision points and identify research gaps. The key output was a structured, evidence-informed framework derived from a systematic search of MEDLINE, Embase, and ClinicalTrials.gov (2000–Dec 2025) combined with expert opinion to guide pragmatic surgical choices. Clinically, it standardizes how clinicians and junior researchers approach evidence synthesis and consensus building for U-POP surgery where high-quality comparative data remain limited.
Gupta A, Grimes CL, Badlani G et al. · International urogynecology journal · (2026) · View on PubMed ↗ · Free PDF ↗
Public Health, Epidemiology & Health Systems
Elevated hydrostatic pressure promotes organic carbon mineralization in reservoir sediments.
The researchers examined how elevated hydrostatic pressure affects organic carbon mineralization in reservoir sediments using a custom-built hydrostatic pressure simulation system (0.1–2.1 MPa) with non-sterilized sediment-water incubations. They found that increasing hydrostatic pressure significantly accelerates sediment organic carbon mineralization, with higher apparent mineralization rates at the upper pressure conditions compared with lower pressures. Scientifically, this clarifies how reservoir-induced pressure regimes can shift carbon cycling and decomposition versus preservation in aquatic sediments.
Zhang Y, Xiao S, Liu D et al. · Water research · (2026) · View on PubMed ↗
The burden of ovarian cancer attributable to occupational asbestos exposure in Asia from 1990 to 2021: an analysis of the global burden of disease study 2021.
This Global Burden of Disease 2021-based analysis quantified the burden of ovarian cancer attributable to occupational asbestos exposure across Asia from 1990 to 2021. It assessed trends in deaths and disability-adjusted life years (DALYs) and reported age-standardized and crude incidence/mortality burden attributable to asbestos exposure. The findings provide region-specific evidence to support occupational health policies and targeted prevention strategies for asbestos-related ovarian cancer risk.
Yu Y, Zhang W, Deng T et al. · Tropical medicine and health · (2026) · View on PubMed ↗ · Free PDF ↗
Adopting common data elements (CDEs) for the National Trauma Research Repository (NTRR): the results of an epidemiology Delphi survey.
This Delphi-survey study, conducted by a multidisciplinary workgroup of military and civilian trauma researchers and data scientists, aimed to define common data elements (CDEs) for the National Trauma Research Repository (NTRR). After reviewing trauma epidemiology databases, codebooks, and collection forms, the group used a three-round Delphi process to reach consensus on recommended baseline CDEs for the NTRR data dictionary. Standardizing these CDEs is scientifically important because it enables more consistent trauma research data capture and improves comparability across studies and systems.
Gurney JM, Medrano NW, Bailey JA et al. · Trauma surgery & acute care open · (2026) · View on PubMed ↗ · Free PDF ↗
Translation, cross-cultural adaptation, and psychometric evaluation of the Arabic version of the University of Wisconsin running injury and recovery index: a reliability and validity study.
This study translated and cross-culturally adapted the University of Wisconsin Running Injury and Recovery Index (UWRI) into Arabic (UWRI-Ar) and evaluated its psychometric reliability and validity in Arabic-speaking runners aged 18–45 years with running-related injury. In 83 participants completing the baseline survey (with 49 retesting after 2–5 days), the UWRI-Ar demonstrated measurement properties consistent with a usable patient-reported outcome tool for injured runners. The clinical significance is that it provides a validated Arabic instrument to assess running injury status and recovery in Arabic-speaking populations.
Aljohani MMA, Alshehri YS, Shuwayhi AM et al. · BMC sports science, medicine & rehabilitation · (2026) · View on PubMed ↗ · Free PDF ↗
Computational/AI/Modeling & Decision Frameworks (non-clinical and clinical tools)
Transcriptomic characterization of Coccidioides morphological states using RiboMarker-enhanced RNA sequencing.
The study profiled small RNA (sRNA) expression across three Coccidioides posadasii morphological states—arthroconidia, mycelia, and spherules—using RiboMarker-enhanced RNA sequencing with intracellular and extracellular RNA fractions. It found that sRNA expression patterns differ by morphology and that RiboMarker improves transcriptome coverage by capturing RNA species typically underrepresented in standard libraries. These results identify morphology-linked sRNA regulators of virulence and provide a foundation for understanding how Coccidioides controls pathogenic transitions.
Howard JM, Manning AC, Clark RC et al. · G3 (Bethesda, Md.) · (2026) · View on PubMed ↗ · Free PDF ↗
Integrative network and structural analysis of Pinus derived phytosterols in diabetes associated pathways.
This in silico pharmacology study used an integrative computational workflow (including network pharmacology) to analyze how two Pinus-derived phytosterols, β-sitosterol and 24-nor-cholest-5,22E-dien-3β-ol, interact with diabetes-related endocrine targets. Network analysis identified ESR1, AR, SHBG, and CYP17A1 as central nodes in pathways linked to endocrine resistance, suggesting these phytosterols may modulate diabetes-associated endocrine signaling. Scientifically, the work generates mechanistic hypotheses for phytosterol-target interactions that could guide future experimental validation in diabetes.
Ali PR, Sri GK, Sravanthi G et al. · In silico pharmacology · (2026) · View on PubMed ↗ · Free PDF ↗
Strategies for resilient climate in smart cities mediated by Nash equilibrium and autonomous decision-makers.
This paper developed a decision-making framework for resilient climate in smart cities by integrating Nash equilibrium, autonomous multi-agent systems, and machine learning to guide city-level policies for pollution and climate-warming risk management. It models each city as an autonomous agent that selects policy actions under strategic interactions captured by Nash equilibrium. The scientific significance is that it offers a computational approach to tailor greenhouse-gas mitigation and resilience strategies to individual cities’ needs while accounting for interdependent decision-making.
Latha CM, Alvarado-Mentado M · Journal of environmental management · (2026) · View on PubMed ↗
Generated automatically on July 09, 2026. Covers PubMed articles published July 02, 2026 – July 09, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.